Bajalan M, Biggs T C, Jayaram S, Mainwaring J, Salib R
Department of ENT Surgery,University Hospital Southampton NHS Foundation Trust,Southampton,UK.
Department of ENT Surgery,Birmingham City Hospital,Southampton,UK.
J Laryngol Otol. 2015 Dec;129(12):1167-73. doi: 10.1017/S0022215115002765.
This study aimed to ascertain otolaryngologists' current knowledge of new (e.g. apixaban, rivaroxaban) and old (e.g. warfarin) anticoagulant medications, and to provide an educational overview of new anticoagulants for use by surgeons.
A questionnaire survey was distributed across the Wessex region, UK, to ascertain the levels of knowledge of and confidence in managing patients taking various anticoagulants. In total, 50 questionnaires were completed (41 by trainees and 9 by consultants). A literature review of new anticoagulant medications was then conducted.
In general, there was poor clinical and pharmacokinetic knowledge of newly licensed anticoagulant medications. Respondents were more confident in the use of older vs newer forms of anticoagulants. This was true across all grades of doctors, but particularly at the senior level. All respondents stated that they would like to see an educational resource on anticoagulants.
Knowledge of newly licensed anticoagulation medications is poor. This study has produced an educational resource for the management of anticoagulant agents. A thorough knowledge of these drugs is essential for the acute management of bleeding patients and in peri-operative surgical planning.
本研究旨在确定耳鼻喉科医生对新型抗凝药物(如阿哌沙班、利伐沙班)和传统抗凝药物(如华法林)的现有了解程度,并为外科医生提供新型抗凝药物的教育概述。
在英国韦塞克斯地区开展了一项问卷调查,以确定管理服用各种抗凝药物患者的知识水平和信心。总共完成了50份问卷(实习医生41份,顾问医生9份)。随后对新型抗凝药物进行了文献综述。
总体而言,对于新获批的抗凝药物,临床和药代动力学知识掌握得较差。受访者对使用传统抗凝药物比新型抗凝药物更有信心。所有级别的医生都是如此,尤其是高级医生。所有受访者均表示希望看到有关抗凝药物的教育资源。
对新获批抗凝药物的了解不足。本研究为抗凝药物管理制作了一份教育资源。深入了解这些药物对于出血患者的紧急处理以及围手术期手术规划至关重要。